Myelodysplastic (MDS) / myeloproliferative (MPN) diseases

Clinical trials for Myelodysplastic (MDS) / myeloproliferative (MPN) diseases explained in plain language.

Never miss a new study

Get alerted when new Myelodysplastic (MDS) / myeloproliferative (MPN) diseases trials appear

Sign up with your email to follow new studies for Myelodysplastic (MDS) / myeloproliferative (MPN) diseases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1

New drug imetelstat targets rare blood cancer in phase 2 trial

Disease control Not yet recruiting

This Phase 2 trial tests the drug imetelstat in 30 adults with myelodysplastic/myeloproliferative neoplasms (MDS/MPN), a rare blood cancer. The goal is to see if imetelstat can help control the disease and to check for side effects. Participants receive the drug by IV, and the st…

Matched conditions: MYELODYSPLASTIC (MDS) / MYELOPROLIFERATIVE (MPN) DISEASES

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

Myelodysplastic (MDS) / myeloproliferative (MPN) diseases

Get alerted when new Myelodysplastic (MDS) / myeloproliferative (MPN) diseases trials appear

New drug imetelstat targets rare blood cancer in phase 2 trial